Cart
sales@molnova.com
1-Deoxynojirimycin
CAS No. 19130-96-2
1-Deoxynojirimycin( Duvoglustat )
Catalog No. M17402 CAS No. 19130-96-2
1-Deoxynojirimycin is a potent α-glucosidase inhibitor, suppressing postprandial blood glucose, thereby possibly preventing diabetes mellitus.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 52 | In Stock |
|
| 2MG | 36 | In Stock |
|
| 5MG | 53 | In Stock |
|
| 10MG | 68 | In Stock |
|
| 25MG | 143 | In Stock |
|
| 50MG | 256 | In Stock |
|
| 100MG | 332 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 799 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name1-Deoxynojirimycin
-
NoteResearch use only, not for human use.
-
Brief Description1-Deoxynojirimycin is a potent α-glucosidase inhibitor, suppressing postprandial blood glucose, thereby possibly preventing diabetes mellitus.
-
Description1-Deoxynojirimycin is a potent α-glucosidase inhibitor, suppressing postprandial blood glucose, thereby possibly preventing diabetes mellitus.
-
In Vitro——
-
In VivoAnimal Model:db/db miceDosage:20, 40, 80 mg/kg Administration:Intravenously; daily for four weeks Result:Significantly reduced body weight, blood glucose and serum insulin levels; Improved glucose tolerance and insulin tolerance.
-
SynonymsDuvoglustat
-
PathwayMetabolic Enzyme/Protease
-
TargetPPAR
-
Recptorβ-glycosidase
-
Research AreaMetabolic Disease
-
Indication——
Chemical Information
-
CAS Number19130-96-2
-
Formula Weight163.17
-
Molecular FormulaC6H13NO4
-
Purity>98% (HPLC)
-
SolubilityH2O : ≥ 34 mg/mL; 208.37 mM
-
SMILESC1[C@@H]([C@H]([C@@H]([C@H](N1)CO)O)O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Jiang P, et al. Sci Rep. 2015 Feb 24;5:8563.
molnova catalog
related products
-
DG172 (dihydrochlori...
DG172 (dihydrochloride) is an ?antagonist of ?PPARβ/δ(IC50 : 27 nM).
-
IVA-337
IVA-337 (Lanifibranor, IVA337)) is a potent, pan PPAR agonist with EC50 of 0.92 uM, 0.53 uM and 0.18 uM for human PPARα, PPARδ and PPARγ respectively.
-
K-111
K-111 (BM-170744) is an orally available peroxisome proliferator-activated receptor (PPAR)-alpha agonist and insulin enhancer for the study of obesity-type diabetes mellitus and the metabolic syndrome.
